• Journal of Advanced Marine Engineering and Technology
• /
• v.1 no.1
• /
• pp.59-74
• /
• 1977

박용분야에 있어서 과거 10년간 가장 진보된 것의 하나는 저동화이다. 과거에 있어서 주기관의 성능과 축계의 강도상의 문제등에 대하여 많은 관심을 가졌던 선박관계자가 그 이상으로 자동화에 대하여 관심을 갖게 된 것은 성역화에 의한 승무원의 노동조건을 개선함과 동시에 자동화에 의한 승조원의 수를 삭감하여 운항비를 낮추어야 할 필요성이 절실히 요망되었기 때문이라고 생각된다. 그러나 석유 파동이후, 세계각국이 저성장기를 맞아 선박자동화도 당분간 별 진전이 없을 것으로 보여진다. 그 1 예로서 일본 NK의 발표에 의하면 각 년도별 MO입급선의 전입급선에 대한 비율이 1972년의 35%를 피이크로 하여 1975년도에는 10%로 감소하고 있다. Computer를 탑재한 초자동화선의 운항척수도 점차 증가 되고 그 신뢰성도 인정이 되고는 있지만 1980년대 전반까지는 초자동화선에 대한 반성기가 계속될 것으로 보아지며, 보다더 가격이 저렴하고 이용율이 높은 Mini-Computer의 사용에 의한 단순화, 통일화가 앞으로 촉진될 것으로 생각된다. 본 원고에서는 선박자동화의 현황과 선박의 Computer Control System에 대해서 극히 개괄적으로 또한 피상적으로 소개하는데 그쳤다. 자동화의 각기기에 대해서는 지면상 언급하지 못하였으니 본 원고 말미의 참고문헌이나 이에 대한 전문서적을 참고하여 주기 바란다. 멀지않은 장래 Computer가 선박운항에 필요 불가결한 기기로 등장할 것만은 사실일 것으로 보아지는 바 선박관계자로 하여금 이러한 분야에 관심을 갖도록 하는데 본고가 다소나마 도움이 되기를 바라마지 않는다.

• Asian Pacific Journal of Cancer Prevention
• /
• v.15 no.23
• /
• pp.10045-10051
• /
• 2015

Chemotherapy is a major therapeutic approach for malignant neoplasms; however, due to the most common adverse events of nausea and vomiting, scheduled chemotherapeutic programs may be impeded or even interrupted, which severely impairs the efficacy. Aprepitants, 5-HT3 antagonists and dexamethasone are primary drugs used to prevent chemotherapy-induced nausea and vomiting (CINV). These drugs have excellent efficacy for control of acute vomiting but are relatively ineffective for delayed vomiting. Aprepitant may remedy this deficiency. Substance P was discovered in the 1930s and its association with vomiting was confirmed in the 1950s. This was followed by a period of non-peptide neurokinin-1 (NK-1) receptor antagonist synthesis and investigation in preclinical studies and clinical trials (phases I, II and III). The FDA granted permission for the clinical chemotherapeutic use of aprepitant in 2003. At present, the combined use of aprepitant, 5-HT3 antagonists and dexamethasone satisfactorily controls vomiting but not nausea. Therefore, new therapeutic approaches and drugs are still needed.

• Bulletin of the Society of Naval Architects of Korea
• /
• v.4 no.1
• /
• pp.59-65
• /
• 1967

Since the screw propellers were adopted as ship propulsion devices, the replacement of propeller shaft due to damage was mostly of fatigue failure due to the alternative stresses [1],[2]. To prevent such a failure, hence, it is suggested that careful attention should be paid to account of the alternative stresses on the design stage of the propeller shafts. In connection with this fact the Ship Classification Societies' Rules are regarded simply as guidance for preliminary determination of the shaft diameter. In this paper, limiting the topic to the small and medium-sized motor ships, an evaluation of the Rules formulae to a theoretical based on Soderberg's correlation [5] between the factor of safety and the resultant stresses obtained by application of the maximum shear theory is done. For this purpose eleven (11) ships built recently in Korea were taken as a species(refer to table 2. in text). In the end the following conclusions are made: (1) In general the Rules formulae give considerably larger size of the propeller shaft diameter than that derived from theoretical calculation, that is, about 7% more in AB and BV Rules, and about 20% more in LR and KR-NK Rules. (2) LR Rule gives the largest size of all, and AB Rule is mostly closed value to the theoretical. (3) The formular of the AB Rule is considered to be of the simplest in utilization and of the reasonable.

• Korean Journal of Food Science and Technology
• /
• v.48 no.3
• /
• pp.268-274
• /
• 2016

The purpose of this study was to investigate the immuno-stimulatory activity of the high-molecular-weight fraction (HMWF) of Cynanchum wilfordii (CW) extracts obtained by ultrafiltration in murine macrophage RAW 264.7 cells and to assess its immuno-stimulatory effect in mice. Ultrafiltration was performed with polyethersulfone membranes (30 kDa cutoff) in a cross-flow filtration system to obtain the HMWF of CW. The results showed that the HMWF increased the production of various cytokines such as tumor necrosis factor-${\alpha}$, interleukin-6, and nitric oxide in dose-ependent manners. In addition, HMWF treatment increased the relative spleen weight as well as splenocyte proliferation induced by concanavalin A or bacterial lipopolysaccharide in mice. Natural killer (NK) cell activity in the HMWF-treated group was significantly increased compared to that in the control group. These results suggest that the HMWF of CW can support the immune system through secretion of macrophage cytokines, thereby enhancing NK cell activity and murine splenocyte proliferation.

• Korean Journal of Head & Neck Oncology
• /
• v.15 no.2
• /
• pp.149-155
• /
• 1999

Objectives: To study the clinical features of the primary nasal/nasopharyngeal non-Hodgkin's lymphomas and to evaluate the implication of immunophenotyping as a prognostic factor. Patients and Methods: From January 1990 to December 1997,41 patients(median age, 41 years) of primary nasal/nasopharyngeal non-Hodgkin's lymphoma were studied. The clinical records and paraffin-embedded tissue blocks were reviewed retrospectively. The histologic features, immunophenotypic findings(pan-T, pan-B, CD3, CD56) and Epstein-Barr virus in situ hybridizatios were examined. The prognostic factors for clinical outcome were evaluated in these patients. According to Ann-Arbor system, there were 30 patiets(73%) with stage IE, 4(10%) with stage IIE, 3(7%) with stage IIIE, 4(10%) with stage IVE lymphoma. Among the patients with stage IE/IIE, 4 patients received local radiation alone, 4 received chemotherapy alone, 25 received combination chemotherapy and radiotherapy and 1 refused treatment. The patients with stage IIIE/IVE were given combination chemotherapy and radiotherapy. Results: Immunophenotyping were performed in 40 patients and staining results were as follows: 3(7%) patients with B cell, 17(42%) with T cell, 18(44%) with NK/T cell(CD56 positive), and two patients with unclassifiable result. Epstein-Barr(EB) virus in situ hybridization were performed in 28 patients and 23(82%) patients had positive EBV-encoded RNAs(EBERs). 21(55%) patients achieved a complete remission. There was no difference in complete remission between radiation alone and combination therapy. With median follow-up of 30 months, 5-years disease free survival of complete responders was 60% and 5-years overall survival rate was 36%. Multivariate analysis showed that better overall survival was related with absence of B symptoms, ECOG performance${\leq}1$ and non-NK cells. Conclusion: Most of all cases were positive for EBER. Since NK/T phenotype carried the worst prognosis, analysis for CD56 expression should be done. Further prospective studies were warranted to evaluate the role of chemotherapy in stage IE/IIE.

• Toxicological Research
• /
• v.6 no.1
• /
• pp.21-28
• /
• 1990

This study was undertaken to evaluate the immune responses to sheep red blood cell (SRBC) and potential anti-tumor effect of Bacillus Calmette-Guerin (BCG) in the mice bearing rumor induced by DMBA. The frequencies of tumor appearances were 62% in DMBA-treated mice and 14% in DMBA and BCG-treated group, respectively. Cellular immune response such as delayed-type hypersensitivity (DTH) to SRBCs, natural killer (NK) cell activity and antigen-binding cell (ABC) assay were decreased apparently in the tumor bearing mice compared to the normal controls. Humoral immune responses such as hemagglutinin (HA) and hemolysin (HE) were noted to be reduced in the tumor bearing mice, but the spleen index increased in tumor bearing mice. All the immunological parameters in the DMBA and BCG-group appeared to be higher than those of only DMBA-treated group. These results indicated that DMBA-induced tumor suppressed host immune responses. Also, they imply the idea that BCG enhanced the immune responses of tumor-bearing host and antitumor effects.

• Korean Journal of Medicinal Crop Science
• /
• v.16 no.1
• /
• pp.9-15
• /
• 2008

Immune-potentiation of Chicorium endivia L. were investigated on follows extracts associated with ultrasonification process at 60 kHz and showed the highest promotion of human B and T cell growth, about $10{\sim}20%$ compared to the control. The secretion of TNF-${\alpha}$ and IL-6 was also enhanced by the addition $(0.5mg/m{\ell})$ of the extracts. NK cell activation was Improved up to 1.37 times higher than the control, through adding extracts. It was also found that extracts from C. endivia L. could yield higher nitric oxide production from macrophage than Lipopolysaccaharides (LPS). It can be concluded that, in general, the extracts treated with ultrasonification has higher immune activity than others, possibly by higher yielding immune-modulatory activity than conventional extraction process. The optimum condition for the extraction of C. endivia L. is ethanol extraction at $60{\sim}100^{\circ}C$ associated with ultrasonification.

• Journal of Korean Biological Nursing Science
• /
• v.6 no.1
• /
• pp.5-15
• /
• 2004

목적 : 이 연구는 항암제를 투여받는 여성암환자에서 발반사마사지가 스트레스반응(활력징후, 코티졸)과 면역반응에 미치는 효과를 평가하기 위함이다. 방법 : 11명의 여성암 환자를 임의로 표출한 후 단일군 전후실험설계로 진행하였다. 종속변수는 스트레스 반응으로 활력징후(수축기 혈압, 이완기 혈압, 맥박수, 호흡수)와 혈중 코티졸, 면역반응으로 림프구 아군(CD3, CD4, CD8, CD19)과 자연살세포(NK cells)이며, 독립변수는 발반사마사지이었다. 중재 전후 종속변수의 변화를 보기 위해 Wilcoxon signed rank test를 실시하였다. 결과 : 중재 전에 비해 중재 후 수축기 혈압, 이완기 혈압, 맥박수, 혈중 코티졸치, CD4와 CD19는 유의한 변화를 보였으나 호흡수, CD3, CD8, 그리고 자연살세포는 유의한 변화를 보이지 않았다. 결론 : 이러한 연구결과는 발반사마사지가 항암화학요법을 받는 여성암 환자의 스트레스 호르몬과 면역관련세포에 영향을 보였지만 표본수가 작고 중재가 1회에 그쳤기 때문에 이러한 단점을 보완한 추후연구를 통해 발반사마사지의 효과를 좀더 잘 규명할 수 있을 것이다.

• Proceedings of the Korean Society of Postharvest Science and Technology of Agricultural Products Conference
• /
• 2007.11a
• /
• pp.27-31
• /
• 2007

This study relates to low and medium molecular weight isoflavone-${\beta}$-D-glucan produced by submerged liquid culture of Agaricus blazei, a method of producing the isoflavone-B-D-glucan using autolysis enzyme of Agaricus blazei mycelia, and use of the isoflavone-B-D-glucan for anti-cancer and immunoenhancing effect. In acordance with one aspect of the present study, it deals with a method of producing isoflavone-${\beta}$-D-glucan, which comprises the followings; 1) culturing and separating mushroom mycelia, 2) producing low-medium molecular weight isoflavone-${\beta}$-D-glucan from high molecular weight one. The cytotoxicity on human cnacer cell line (Caco-2, MCF-7), the expression of Cyclin D, Bcl-2, Bax protein, p21 protein, p53 protein in MCF-7 cells assessed by SDS-PAGE and immunoblotting, and other immuno related factors such as TNF-${\alpha}$ and IL-1B activities were examined. Structural identification of isoflavone-${\beta}$-D-glucan which showed cytotoxicity against cancer cell and immunoenhancing effects was carried by separation with DEAE-cellulose column chromatography, TLC, HPLC, IR, NMR. Clinical test for the cancer patients (n=119) for 6 month was carried out, and immunoenhancing factors (NK. cell number, ratio of T4/T8) were checked. We concluded the identified isoflavone-${\beta}$-D-glucan has immuno enhancing effects and could be useful for cancer chemoprevention.

• Journal of the Korean Society of Laryngology, Phoniatrics and Logopedics
• /
• v.24 no.2
• /
• pp.118-121
• /
• 2013

Primary lymphoma of the larynx is rare, accounting for less than 1% of all laryngeal neoplasm. Early symptoms are ambiguous and nonspecific, and confirmation of the diagnosis is often difficult. The aim of this study was to report the experience of our department in the management of these aggressive lesions, as they require special diagnostic and therapeutic attention. We enrolled 3 patients who diagnosis of lymphoma involving the larynx were retrospectively reviewed. The histopathological diagnosis revealed 1 case of diffuse large B cell lymphoma, and 2 case of NK-T cell lymphoma. Details of the presentation, diagnostic procedures, treatment, and outcome of these patients were presented. Primary laryngeal lymphoma is a rare entity. Early symptoms are subtle and nonspecific, and confirmation of the diagnosis is often difficult. Because of the rarity of this tumor type, the optimal management remains controversial and it seems that should be managed not as a distinct disease entity but as an unusual presentation of non-Hodgkin lymphoma, according to the recent treatment trends.